In recent years, increased scrutiny over the impacts of consolidation in the healthcare industry has driven both antitrust enforcers and policymakers at the federal and state levels to enhance their efforts to address and remedy the source of the issue by improving oversight and review of potential anticompetitive healthcare mergers and acquisitions, both before and after the transaction. As the federal agencies review and revise their merger review guidelines and reporting requirements, several states have also introduced legislation to enhance their review and oversight authority of healthcare transactions in their state. In 2021, Oregon [...]
Oregon Association of Hospitals and Health Systems, the trade group for hospitals in Oregon, filed a suit in district court on October 3, 2022 against the state. The group seeks to overturn House Bill 2362, which passed in 2021 and requires health care entities to provide notice and obtain approval from the Oregon Health Authority before moving forward with any mergers, acquisitions, or affiliations of entities that had $25 million or more in net patient revenue in three fiscal years preceding the transaction, if the transaction will result in one entity experiencing an increase [...]
PhRMA is challenging Oregon's drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are unconstitutional because they violate the Commerce Clause, First Amendment, the Takings Clause, and trade secret protections. The Disclosure Law, which went into effect at the beginning of 2019, required drug makers to notify the state and provide detailed information when list prices rise by at least 10% or a new medicine is introduced that costs more than $670 for a month's supply. The Advance Notification Law, which had not [...]
Exempts rehabilitation facilities from requirement to obtain certificate of need. Exempts rehabilitation facilities from requirement to obtain certificate of need.